West Pharmaceutical Services: HVP Moat Cum GLP-1 And Biologics Tailwinds Reinforce Upward Momentum

Core Insights - The expectation for HVP component revenues is projected to grow in the mid- to high-single digits in 2025, indicating a positive outlook for this segment [1] Group 1: Revenue Growth - HVP component revenues are anticipated to grow mid- to high-single digits in 2025 [1] - There is an expected continued mix shift towards HVP in 2025 and beyond, suggesting a strategic focus on this area [1]